These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Chemoprevention of chemically-induced mammary and colon carcinogenesis by 1alpha-hydroxyvitamin D5. Murillo G; Mehta RG J Steroid Biochem Mol Biol; 2005 Oct; 97(1-2):129-36. PubMed ID: 16051482 [TBL] [Abstract][Full Text] [Related]
3. Prevention of preneoplastic mammary lesion development by a novel vitamin D analogue, 1alpha-hydroxyvitamin D5. Mehta RG; Moriarty RM; Mehta RR; Penmasta R; Lazzaro G; Constantinou A; Guo L J Natl Cancer Inst; 1997 Feb; 89(3):212-8. PubMed ID: 9017001 [TBL] [Abstract][Full Text] [Related]
4. Growth inhibition of carcinogen-transformed MCF-12F breast epithelial cells and hormone-sensitive BT-474 breast cancer cells by 1alpha-hydroxyvitamin D5. Hussain-Hakimjee EA; Peng X; Mehta RR; Mehta RG Carcinogenesis; 2006 Mar; 27(3):551-9. PubMed ID: 16195238 [TBL] [Abstract][Full Text] [Related]
5. Prevention of N-methyl-N-nitrosourea-induced mammary carcinogenesis in rats by 1alpha-hydroxyvitamin D(5). Mehta R; Hawthorne M; Uselding L; Albinescu D; Moriarty R; Christov K; Mehta R J Natl Cancer Inst; 2000 Nov; 92(22):1836-40. PubMed ID: 11078761 [TBL] [Abstract][Full Text] [Related]
6. Chemoprevention of mammary carcinogenesis by 1alpha-hydroxyvitamin D5, a synthetic analog of Vitamin D. Mehta RG; Hussain EA; Mehta RR; Das Gupta TK Mutat Res; 2003; 523-524():253-64. PubMed ID: 12628523 [TBL] [Abstract][Full Text] [Related]
7. Relative efficacy of the opioid antagonist, naltrexone, on the initiation and promotion phases of rat mammary carcinogenesis. Koo KL; Tejwani GA; Abou-Issa H Anticancer Res; 1996; 16(4A):1893-8. PubMed ID: 8712718 [TBL] [Abstract][Full Text] [Related]
8. Dietary effects of conjugated docosahexaenoic acid on N-methyl-N-nitrosourea-induced mammary carcinogenesis in female Sprague-Dawley rats. Danbara N; Uehara N; Shikata N; Takada H; Hada T; Tsubura A Oncol Rep; 2004 Nov; 12(5):1079-85. PubMed ID: 15492796 [TBL] [Abstract][Full Text] [Related]
9. Prophylaxis of mammary neoplasia by selenium supplementation in the initiation and promotion phases of chemical carcinogenesis. Ip C Cancer Res; 1981 Nov; 41(11 Pt 1):4386-90. PubMed ID: 6796257 [TBL] [Abstract][Full Text] [Related]
10. Nimesulide and melatonin in mammary carcinogenesis prevention in female Sprague-Dawley rats. Kubatka P; Kalická K; Chamilová M; Ahlersová E; Ahlers I; Bojková B; Adámeková E Neoplasma; 2002; 49(4):255-9. PubMed ID: 12382025 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of DMBA-initiated rat mammary tumour development by 1-O-hexyl-2,3,5-trimethylhydroquinone, phenylethyl isothiocyanate, and novel synthetic ascorbic acid derivatives. Futakuchi M; Hirose M; Miki T; Tanaka H; Ozaki M; Shirai T Eur J Cancer Prev; 1998 Apr; 7(2):153-9. PubMed ID: 9818778 [TBL] [Abstract][Full Text] [Related]
12. 25-Hydroxyvitamin D3 is a natural chemopreventive agent against carcinogen induced precancerous lesions in mouse mammary gland organ culture. Peng X; Hawthorne M; Vaishnav A; St-Arnaud R; Mehta RG Breast Cancer Res Treat; 2009 Jan; 113(1):31-41. PubMed ID: 18205042 [TBL] [Abstract][Full Text] [Related]
13. Relative efficacy of glucarate on the initiation and promotion phases of rat mammary carcinogenesis. Abou-Issa H; Moeschberger M; el-Masry W; Tejwani S; Curley RW; Webb TE Anticancer Res; 1995; 15(3):805-10. PubMed ID: 7645962 [TBL] [Abstract][Full Text] [Related]
14. Effects of dietary folate on the development and progression of mammary tumors in rats. Kotsopoulos J; Medline A; Renlund R; Sohn KJ; Martin R; Hwang SW; Lu S; Archer MC; Kim YI Carcinogenesis; 2005 Sep; 26(9):1603-12. PubMed ID: 15888495 [TBL] [Abstract][Full Text] [Related]
15. [Neoplastic effect of indomethacin in N-methyl-N-nitrosourea induced mammary carcinogenesis in female rats]. Kubatka P; Kalická K; Bojková B; Ahlers I; Ahlersová E; Péč M Klin Onkol; 2012; 25(5):359-63. PubMed ID: 23102197 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and mechanism of action of 1alpha-hydroxy-24-ethyl-cholecalciferol (1alpha[OH]D5) in breast cancer prevention and therapy. Hussain EA; Mehta RR; Ray R; Das Gupta TK; Mehta RG Recent Results Cancer Res; 2003; 164():393-411. PubMed ID: 12899538 [TBL] [Abstract][Full Text] [Related]
17. 1 alpha,25-Dihydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol (Ro24-5531), a new deltanoid (vitamin D analogue) for prevention of breast cancer in the rat. Anzano MA; Smith JM; Uskoković MR; Peer CW; Mullen LT; Letterio JJ; Welsh MC; Shrader MW; Logsdon DL; Driver CL Cancer Res; 1994 Apr; 54(7):1653-6. PubMed ID: 8137276 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of ER and VDR is not sufficient to make ER-negative MDA-MB231 breast cancer cells responsive to 1alpha-hydroxyvitamin D5. Peng X; Jhaveri P; Hussain-Hakimjee EA; Mehta RG Carcinogenesis; 2007 May; 28(5):1000-7. PubMed ID: 17130524 [TBL] [Abstract][Full Text] [Related]
19. Effect of tamoxifen on mammary preneoplasia: relevance to chemopreventive intervention. Telang NT; Bradlow HL; Osborne MP Cancer Detect Prev; 1994; 18(4):313-21. PubMed ID: 7982241 [TBL] [Abstract][Full Text] [Related]
20. Effects of prepubertal indole-3-carbinol treatment on development of N-methyl-N-nitrosourea-induced mammary carcinomas in female Sprague-Dawley rats. Shimano N; Uehara N; Kiyozuka Y; Shikata N; Tsubura A In Vivo; 2007; 21(6):983-8. PubMed ID: 18210745 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]